ClinicalTrials.govpublic full text
An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD
neovascular age-related macular degeneration, neovascularization, age-related macular degeneration, ranibizumab (lucentis), optical coherence tomography, intravitreal injection, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845632
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.